WW domain-containing ubiquitin E3 ligase 1 regulates immune infiltration in tumor microenvironment of ovarian cancer.
10.12122/j.issn.1673-4254.2025.05.20
- Author:
Xiaojuan GUO
1
;
Ruijuan DU
1
;
Liping CHEN
1
;
Kelei GUO
1
;
Biao ZHOU
1
;
Hua BIAN
1
;
Li HAN
1
Author Information
1. Zhang Zhongjing College of Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, China.
- Publication Type:Journal Article
- Keywords:
WW domain-containing ubiquitin E3 ligase 1;
immune infiltration;
ovarian cancer;
tumor microenvironment
- MeSH:
Female;
Ovarian Neoplasms/genetics*;
Humans;
Ubiquitin-Protein Ligases/metabolism*;
Tumor Microenvironment/immunology*;
Animals;
Mice;
Cell Line, Tumor;
Mice, Nude;
Prognosis;
Gene Expression Regulation, Neoplastic
- From:
Journal of Southern Medical University
2025;45(5):1063-1073
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To explore the association of the expression of WW domain-containing ubiquitin E3 ligase 1 (WWP1) with immune infiltration in tumor microenvironment (TME) of ovarian cancer.
METHODS:Ovarian cancer patient data from The Cancer Genome Atlas (TCGA) were used to analyze the association of WWP1 expression with patient prognosis. TISCH2 was utilized to analyze the changes in immune cell subtypes in TME of metastatic tumor and after chemotherapy. The impact of WWP1 on immune cell infiltration, somatic copy number alterations of WWP1 and evolution of immune cell subtypes was evaluated using TIMER and TIGER pseudo-time analysis. A deep learning model was used to analyze TCGA pathological images to investigate the effect of WWP1 on TME of ovarian cancer. RNA-seq analysis was conducted to identify the differentially expressed genes in WWP1-overexpressing SKOV3 cells and validate immune infiltration. Multicolor immunofluorescence assay was used to analyze the immune markers in SKOV3 and SKOV3/DDP cell xenografts in nude mice.
RESULTS:The patients with high WWP1 expression levels had significantly lower overall survival rate (P=0.0012). High WWP1 expression levels and Stage IV disease were both associated with a poor prognosis (P<0.05). In metastatic ovarian cancer or after chemotherapy, the percentages of malignant tumor cells and tumor-associated fibroblasts increased in the TME, accompanied by elevated WWP1 levels. WWP1 expression level was positively correlated with pro-tumorigenic immunosuppressive cells (r=0.1323-0.3955, P<0.05) and negatively with tumor-inhibiting immune cells (r=-0.1949- -0.1333, P<0.05). Specific copy number alterations of WWP1 also influenced CD8+ T cell percentage and neutrophil infiltration levels in the TME. RNA-seq analysis of WWP1-overexpressing SKOV3 cells and immunofluorescence assay of the tumor-bearing mice yielded findings consistent with those of bioinformatics analysis.
CONCLUSIONS:WWP1 may serve as a prognostic biomarker and a potential target for immune regulation in the TME of ovarian cancer.
